週次 |
日期 |
單元主題 |
第2週 |
2/24 |
新春開始-暫停一次 |
第3週 |
3/3 |
Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery (核心能力2,4,7) |
第4週 |
3/10 |
Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin(核心能力2,4,7) |
第5週 |
3/17 |
Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations.(核心能力2,4,7) |
第6週 |
3/24 |
Folate-Targeted Polymeric Nanoparticle Formulation of Docetaxel Is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of Radiotherapy (核心能力2,4,7) |
第7週 |
3/31 |
superhydrophobic surfaces as a tool for the fabrication of hierarchical spherical polymeric carriers (核心能力2,4,7) |
第8週 |
4/7 |
A hematoporphyrin-based delivery system for drug resistance reversal and tumor ablation (核心能力2,4,7) |
第9週 |
4/14 |
Poly-ε-caprolactone mesh as a scaffold for in vivo tissue engineering in rabbit esophagus (核心能力2,4,7) |
第10週 |
4/21 |
期中考-暫停一次 |
第11週 |
4/28 |
Apoferritin Modified Magnetic Particles as Doxorubicin Carriers for Anticancer Drug Delivery (核心能力2,4,7) |
第12週 |
5/5 |
Investigation of thermo-sensitive amphiphilic micelles as drug carriers for chemotherapy in cholangiocarcinoma in vitro and in vivo.(核心能力2,4,7) |
第13週 |
5/12 |
H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.(核心能力2,4,7) |
第14週 |
5/19 |
Lack of in Vivo Antibody Dependent Cellular Cytotoxicity with
Antibody Containing Gold Nanoparticles
(核心能力2,4,7) |
第15週 |
5/26 |
Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors(核心能力2,4,7) |
第16週 |
6/2 |
教授出席國際會議-暫停一次 |
第17週 |
6/9 |
Synthesis and biological evaluation of
panitumumab–IRDye800 conjugate as a
fluorescence imaging probe for EGFR-expressing
cancers
(核心能力2,4,7) |
第18週 |
6/16 |
Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma(核心能力2,4,7) |
第19週 |
6/23 |
期末考-暫停一次 |